TrialThe New England journal of medicine2016
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
Alain Ravaud et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
344 papers cite itlatest 60 shown
this paperpooled ittrialcites it